Innate immune evasion by filoviruses.

[1]  C. Basler,et al.  Amino Acid Residue at Position 79 of Marburg Virus VP40 Confers Interferon Antagonism in Mouse Cells. , 2015, The Journal of infectious diseases.

[2]  Sky W. Brubaker,et al.  Innate immune pattern recognition: a cell biological perspective. , 2015, Annual review of immunology.

[3]  C. Basler,et al.  The VP40 Protein of Marburg Virus Exhibits Impaired Budding and Increased Sensitivity to Human Tetherin following Mouse Adaptation , 2014, Journal of Virology.

[4]  Stephan Günther,et al.  Emergence of Zaire Ebola virus disease in Guinea. , 2014, The New England journal of medicine.

[5]  T. Geisbert.  Medical research: Ebola therapy protects severely ill monkeys , 2014, Nature.

[6]  X. Qiu,et al.  Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents , 2014, Vaccine.

[7]  L. Mulder,et al.  Molecular Basis for Ebolavirus VP35 Suppression of Human Dendritic Cell Maturation , 2014, Journal of Virology.

[8]  Wei Xu,et al.  Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1. , 2014, Cell host & microbe.

[9]  Wei Xu,et al.  The Marburg virus VP24 protein interacts with Keap1 to activate the cytoprotective antioxidant response pathway. , 2014, Cell reports.

[10]  V. Lotteau,et al.  Marburgvirus hijacks nrf2-dependent pathway by targeting nrf2-negative regulator keap1. , 2014, Cell reports.

[11]  Dafna M. Abelson,et al.  Crystal Structure of Marburg Virus VP24 , 2014, Journal of Virology.

[12]  L. Ivashkiv,et al.  Regulation of type I interferon responses , 2013, Nature Reviews Immunology.

[13]  G. Neumann,et al.  The Cytoprotective Enzyme Heme Oxygenase-1 Suppresses Ebola Virus Replication , 2013, Journal of Virology.

[14]  H. Ebihara,et al.  Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. , 2013, Cell host & microbe.

[15]  I. Wilson,et al.  Ebolavirus VP35 Coats the Backbone of Double-Stranded RNA for Interferon Antagonism , 2013, Journal of Virology.

[16]  Sunyoung Kim,et al.  Upregulation of Nrf2 expression by human cytomegalovirus infection protects host cells from oxidative stress. , 2013, The Journal of general virology.

[17]  Heinz Feldmann,et al.  Filoviridae: Marburg and ebola viruses , 2013 .

[18]  Jennifer A. Doudna,et al.  Differential roles of human Dicer-binding proteins TRBP and PACT in small RNA processing , 2013, Nucleic acids research.

[19]  R. Koup,et al.  The Lack of Maturation of Ebola Virus-Infected Dendritic Cells Results from the Cooperative Effect of at Least Two Viral Domains , 2013, Journal of Virology.

[20]  H. Feldmann,et al.  An Upstream Open Reading Frame Modulates Ebola Virus Polymerase Translation and Virus Replication , 2013, PLoS pathogens.

[21]  W. Kwan,et al.  Stimulation of NF-κB Activity by the HIV Restriction Factor BST2 , 2012, Journal of Virology.

[22]  Z. Otwinowski,et al.  Structural basis for Marburg virus VP35–mediated immune evasion mechanisms , 2012, Proceedings of the National Academy of Sciences.

[23]  Timothy D. Flietstra,et al.  Seasonal Pulses of Marburg Virus Circulation in Juvenile Rousettus aegyptiacus Bats Coincide with Periods of Increased Risk of Human Infection , 2012, PLoS pathogens.

[24]  I. MacRae,et al.  Marburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon Antagonism , 2012, PLoS pathogens.

[25]  P. Bates,et al.  Identification of Alternatively Translated Tetherin Isoforms with Differing Antiviral and Signaling Activities , 2012, PLoS pathogens.

[26]  G. Superti-Furga,et al.  Viral immune modulators perturb the human molecular network by common and unique strategies , 2012, Nature.

[27]  P. Cannon,et al.  Anti-Tetherin Activities of HIV-1 Vpu and Ebola Virus Glycoprotein Do Not Involve Removal of Tetherin from Lipid Rafts , 2012, Journal of Virology.

[28]  Dafna M. Abelson,et al.  The Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold , 2012, PLoS pathogens.

[29]  Yali Zhu,et al.  Characterization of the RNA Silencing Suppression Activity of the Ebola Virus VP35 Protein in Plants and Mammalian Cells , 2012, Journal of Virology.

[30]  C. Basler,et al.  The Ebola virus VP24 protein prevents hnRNP C1/C2 binding to karyopherin α1 and partially alters its nuclear import. , 2011, The Journal of infectious diseases.

[31]  C. Basler,et al.  Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells , 2011, Immunology and cell biology.

[32]  S. Kochetkov,et al.  Hepatitis C Virus Proteins Activate NRF2/ARE Pathway by Distinct ROS-Dependent and Independent Mechanisms in HUH7 Cells , 2011, PloS one.

[33]  S. Au,et al.  The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. , 2011, Cell host & microbe.

[34]  S. Simmons,et al.  Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells , 2011, Free Radical Biology and Medicine.

[35]  H. Feldmann,et al.  Ebola haemorrhagic fever , 2011, The Lancet.

[36]  C. Basler,et al.  Marburg Virus VP40 Antagonizes Interferon Signaling in a Species-Specific Manner , 2011, Journal of Virology.

[37]  S. Bavari,et al.  Key Genomic Changes Necessary for an In Vivo Lethal Mouse Marburgvirus Variant Selection Process , 2011, Journal of Virology.

[38]  Masayuki Yamamoto,et al.  Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution , 2011, Genes to cells : devoted to molecular & cellular mechanisms.

[39]  R. Wek,et al.  Phosphorylation of eIF2 Facilitates Ribosomal Bypass of an Inhibitory Upstream ORF to Enhance CHOP Translation*♦ , 2011, The Journal of Biological Chemistry.

[40]  N. Sullivan,et al.  Ebolavirus Proteins Suppress the Effects of Small Interfering RNA by Direct Interaction with the Mammalian RNA Interference Pathway , 2011, Journal of Virology.

[41]  C. Ahn,et al.  Suppression of NF-kappaB signaling by KEAP1 regulation of IKKbeta activity through autophagic degradation and inhibition of phosphorylation. , 2010, Cellular signalling.

[42]  S. Werner,et al.  Hepatitis B Virus Induces Expression of Antioxidant Response Element-regulated Genes by Activation of Nrf2* , 2010, The Journal of Biological Chemistry.

[43]  G. Ruthel,et al.  Infectious Lassa Virus, but Not Filoviruses, Is Restricted by BST-2/Tetherin , 2010, Journal of Virology.

[44]  C. Basler,et al.  Structural and functional characterization of Reston Ebola virus VP35 interferon inhibitory domain. , 2010, Journal of molecular biology.

[45]  P. Cannon,et al.  Ebola Virus Glycoprotein Counteracts BST-2/Tetherin Restriction in a Sequence-Independent Manner That Does Not Require Tetherin Surface Removal , 2010, Journal of Virology.

[46]  E. White,et al.  A Noncanonical Mechanism of Nrf2 Activation by Autophagy Deficiency: Direct Interaction between Keap1 and p62 , 2010, Molecular and Cellular Biology.

[47]  Mihee M. Kim,et al.  The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1 , 2010, Nature Cell Biology.

[48]  G. Waris,et al.  Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway. , 2010, The Journal of general virology.

[49]  Z. Otwinowski,et al.  Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35 , 2010, Nature Structural &Molecular Biology.

[50]  B. Prabhakar,et al.  The VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide. , 2010, The Journal of general virology.

[51]  V. Volchkov,et al.  Mutations Abrogating VP35 Interaction with Double-Stranded RNA Render Ebola Virus Avirulent in Guinea Pigs , 2010, Journal of Virology.

[52]  C. Basler,et al.  Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus , 2010, PLoS pathogens.

[53]  Virgil L. Woods,et al.  Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression , 2009, Proceedings of the National Academy of Sciences.

[54]  M. Hung,et al.  KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta. , 2009, Molecular cell.

[55]  J. Gonzalez,et al.  Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus , 2009, BMC infectious diseases.

[56]  C. Basler,et al.  Evasion of interferon responses by Ebola and Marburg viruses. , 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[57]  Alan Kemp,et al.  Isolation of Genetically Diverse Marburg Viruses from Egyptian Fruit Bats , 2009, PLoS pathogens.

[58]  E. Mühlberger,et al.  Ebola Virus VP35 Antagonizes PKR Activity through Its C-Terminal Interferon Inhibitory Domain , 2009, Journal of Virology.

[59]  Steven B. Bradfute,et al.  Ebola Zaire Virus Blocks Type I Interferon Production by Exploiting the Host SUMO Modification Machinery , 2009, PLoS pathogens.

[60]  P. Bates,et al.  Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein , 2009, Proceedings of the National Academy of Sciences.

[61]  C. Basler,et al.  Ebola Virus Protein VP35 Impairs the Function of Interferon Regulatory Factor-Activating Kinases IKKε and TBK-1 , 2009, Journal of Virology.

[62]  F. Polack,et al.  Antiviral Activity of Nrf2 in a Murine Model of Respiratory Syncytial Virus Disease at a Glance Commentary , 2022 .

[63]  P. Bieniasz,et al.  Broad-Spectrum Inhibition of Retroviral and Filoviral Particle Release by Tetherin , 2008, Journal of Virology.

[64]  J. Strong,et al.  Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway , 2008, Proceedings of the National Academy of Sciences.

[65]  N. Kitteringham,et al.  The Nrf2-Keap1 defence pathway: role in protection against drug-induced toxicity. , 2008, Toxicology.

[66]  Steven B. Bradfute,et al.  Development of a model for marburgvirus based on severe-combined immunodeficiency mice , 2007, Virology Journal.

[67]  C. Basler,et al.  Ebola Virus VP24 Proteins Inhibit the Interaction of NPI-1 Subfamily Karyopherin α Proteins with Activated STAT1 , 2007, Journal of Virology.

[68]  B. Berkhout,et al.  The Ebola Virus VP35 Protein Is a Suppressor of RNA Silencing , 2007, PLoS pathogens.

[69]  M. Hannink,et al.  PGAM5, a Bcl-XL-interacting Protein, Is a Novel Substrate for the Redox-regulated Keap1-dependent Ubiquitin Ligase Complex* , 2006, Journal of Biological Chemistry.

[70]  Zongdi Feng,et al.  The VP35 Protein of Ebola Virus Inhibits the Antiviral Effect Mediated by Double-Stranded RNA-Dependent Protein Kinase PKR , 2006, Journal of Virology.

[71]  V. Volchkov,et al.  Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear Accumulation , 2006, Journal of Virology.

[72]  Erica Ollmann Saphire,et al.  Ebola Virus VP35 Protein Binds Double-Stranded RNA and Inhibits Alpha/Beta Interferon Production Induced by RIG-I Signaling , 2006, Journal of Virology.

[73]  M. Katze,et al.  Global Suppression of the Host Antiviral Response by Ebola- and Marburgviruses: Increased Antagonism of the Type I Interferon Response Is Associated with Enhanced Virulence , 2006, Journal of Virology.

[74]  T. Anthony,et al.  Coping with stress: eIF2 kinases and translational control. , 2006, Biochemical Society transactions.

[75]  C. Basler,et al.  Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein. , 2005, Virology.

[76]  M. Bray,et al.  Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. , 2005, The international journal of biochemistry & cell biology.

[77]  S. Nichol,et al.  A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus. , 2004, Virology.

[78]  R. Wek,et al.  Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[79]  C. Horvath,et al.  Identification of the Nuclear Export Signal and STAT-Binding Domains of the Nipah Virus V Protein Reveals Mechanisms Underlying Interferon Evasion , 2004, Journal of Virology.

[80]  P. Jahrling,et al.  Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. , 2003, The American journal of pathology.

[81]  G. Ruthel,et al.  Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation. , 2003, The Journal of infectious diseases.

[82]  Kevin M. McBride,et al.  The Ins and Outs of STAT1 Nuclear Transport , 2003, Science's STKE.

[83]  H. Klenk,et al.  The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3 , 2003, Journal of Virology.

[84]  B. Pulendran,et al.  Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses1 , 2003, The Journal of Immunology.

[85]  V. Volchkov,et al.  The Ebola virus VP35 protein functions as a type I IFN antagonist. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[86]  A. Sanchez,et al.  Ebola Virus Selectively Inhibits Responses to Interferons, but Not to Interleukin-1β, in Endothelial Cells , 1999, Journal of Virology.

[87]  Stephan Becker,et al.  Comparison of the Transcription and Replication Strategies of Marburg Virus and Ebola Virus by Using Artificial Replication Systems , 1999, Journal of Virology.

[88]  H. Klenk,et al.  Three of the Four Nucleocapsid Proteins of Marburg Virus, NP, VP35, and L, Are Sufficient To Mediate Replication and Transcription of Marburg Virus-Specific Monocistronic Minigenomes , 1998, Journal of Virology.

[89]  G. Sen,et al.  PACT, a protein activator of the interferon‐induced protein kinase, PKR , 1998, The EMBO journal.

[90]  R. Schreiber,et al.  Disruption of the Jak1 Gene Demonstrates Obligatory and Nonredundant Roles of the Jaks in Cytokine-Induced Biologic Responses , 1998, Cell.

[91]  M. Katze,et al.  Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. , 1998, Pharmacology & therapeutics.

[92]  S. Neil.  The antiviral activities of tetherin. , 2013, Current topics in microbiology and immunology.

[93]  I. Copple.  The Keap1-Nrf2 cell defense pathway--a promising therapeutic target? , 2012, Advances in pharmacology.

[94]  V. Volchkov,et al.  Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. , 2006, Journal of virology.

[95]  S. Hazar,et al.  Filoviridae: Marburg and Ebola viruses. , 2000 .

[96]  H. Feldmann,et al.  Marburg and Ebola viruses. , 1996, Advances in virus research.